Corrigendum to article ‘Prevention of Epileptogenesis - A New Goal for Epilepsy Therapy’ (Prevention of Epileptogenesis—A New Goal for Epilepsy Therapy (2014) 51(6) (758–759), (S0887899414005256), (10.1016/j.pediatrneurol.2014.08.019));Prevention of epileptogenesis - A new goal for epilepsy therapy

Pediatric Neurology

Volumn 51, Issue 6, 2014, Pages 758-759

  Jóźwiak, Sergiusz ^a   Kotulska, Katarzyna ^a  

^a CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; ETHOSUXIMIDE; ETIRACETAM; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID; VIGABATRIN;

ANTICONVULSANT THERAPY; DIFFUSION TENSOR IMAGING; ELECTROENCEPHALOGRAPHY; EPILEPSY; EPILEPTOGENESIS; GENETIC PREDISPOSITION; HUMAN; INTELLIGENCE QUOTIENT; NEUROIMAGING; NONHUMAN; SEIZURE SUSCEPTIBILITY; SENSORY STIMULATION; SHORT SURVEY;

EID: 84912121449     PISSN: 08878994     EISSN: 18735150     Source Type: Journal    
DOI: 10.1016/j.pediatrneurol.2022.08.005     Document Type: Erratum

References (10)

1. Yan HD, Ji-qun C, Ishihara K, et al. Separation of antiepileptogenic and antiseizure effects of levetiracetam in the spontaneously epileptic rat (SER). Epilepsia. 2005;46:1170-1177.
2. Blumenfeld H, Klein JP, Schridde U, et al. Early treatment suppresses the development of spike-wave epilepsy in a rat model. Epilepsia. 2008;49:400-409.
3. Luijtelaar G, Mishra AM, Edelbroek P, et al. Anti-epileptogenesis: electrophysiology, diffusion tensor imaging and behavior in a genetic absence epilepsy model. Neurobiol Dis. 2013;60:126-138.
4. Temkin NR. Preventing and treating posttraumatic seizures: the human experience. Epilepsia. 2009;50(Suppl. 2):10-13.
5. French JA, White HS, Klitgaard H, et al. Development of new treatment approaches for epilepsy: unmet needs and opportunities. Epilepsia. 2013;54(Suppl.4):3-12.
6. Talos DA, Sun H, Zhou X, et al. The interaction between early life epilepsy and autistic-like behavioral consequences: a role for the mammalian target of rapamycin (mTOR) pathway. PLOS One. 2012;7:e35885.
7. Ville D, Enjolras O, Chiron C, Dulac O. Prophylactic antiepileptic treatment in Sturge-Weber disease. Seizure. 2002;11:145-150.
8. Jozwiak S, Kotulska K, Domanska-Pakiela D, et al. Antiepileptic treatment before the onset of seizures reduces epilepsy severity and risk of mental retardation in infants with tuberous sclerosis complex. Eur.J.Paediatr.Neurol. 2011;15:424-431.
9. Fisher RS, Acevedo C, Arzimanoglou A, et al. A practical clinical definition of epilepsy. Epilepsia. 2014;55:475-482.
10. Domanska-Pakiela D, Kaczorowska M, Jurkiewicz E, et al. EEG abnormalities preceding the epilepsy onset in tuberous sclerosis complex patients - a prospective study of 5 patients. Eur J Paediatr Neurol. 2014;18:458-468.